EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice

Annals of the Rheumatic Diseases

Volumn 77, Issue 5, 2018, Pages 636-643

  Dejaco, Christian ^a,b   Ramiro, Sofia ^c   Duftner, Christina ^d   Besson, Florent L ^e   Bley, Thorsten A ^f   Blockmans, Daniel ^g   Brouwer, Elisabeth ^h   Cimmino, Marco A ⁱ   Clark, Eric ^j   Dasgupta, Bhaskar ^k,l   DIamantopoulos, Andreas P ^m   DIreskeneli, Haner ⁿ   Iagnocco, Annamaria ^o   Klink, Thorsten ^f   Neill, Lorna ^p   Ponte, Cristina ^q,r   Salvarani, Carlo ^s,t   Slart, Riemer H J A ^h,u   Whitlock, Madeline ^k   Schmidt, Wolfgang A ^v  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b Hospital of Bruneck   (Italy)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^e UNIVERSITÉ PARIS SACLAY   (France)

^f UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^g UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^h UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j Giant Cell Arteritis UK   (United Kingdom)

^k Department of Oncology   (United Kingdom)

^l ANGLIA RUSKIN UNIVERSITY   (United Kingdom)

^m MARTINA HANSENS HOSPITAL   (Norway)

ⁿ MARMARA UNIVERSITY   (Turkey)

^o UNIVERSITY OF TURIN   (Italy)

^p Polymyalgia Rheumatica   (United Kingdom)

^q INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^r HOSPITAL DE SANTA MARIA   (Portugal)

^s PATHOLOGY UNIT   (Italy)

^t UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^u UNIVERSITY OF TWENTE   (Netherlands)

^v MARTIN LUTHER KRANKENHAUS   (Germany)

more..

Author keywords

giant cell arteritis; magnetic resonance imaging; systemic vasculitis; ultrasonography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

AORTIC ARCH SYNDROME; AORTIC RUPTURE; ARTICLE; BLOOD VESSEL BIOPSY; CARDIAC IMAGING; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL EXAMINATION; CLINICAL PRACTICE; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; ECHOCARDIOGRAPHY; EVIDENCE BASED PRACTICE; GENERAL PRACTITIONER; GIANT CELL ARTERITIS; HEALTH CARE PERSONNEL; HUMAN; LARGE VESSEL VASCULITIS; MEDICAL EXPERT; MORBIDITY; PATIENT MONITORING; PATIENT RISK; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TEMPORAL ARTERY; VASCULITIS; CONSENSUS DEVELOPMENT; DIAGNOSTIC IMAGING; ECHOGRAPHY; EUROPE; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCEDURES; RHEUMATOLOGY; STANDARDS; X-RAY COMPUTED TOMOGRAPHY;

EUROPE; FLUORODEOXYGLUCOSE F18; GIANT CELL ARTERITIS; HUMANS; MAGNETIC RESONANCE IMAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; RHEUMATOLOGY; TAKAYASU ARTERITIS; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY; VASCULITIS;

EID: 85041402195     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2017-212649     Document Type: Article

References (55)

1. Sfmeeth L, Cook C, Hall AJ. Incidence of diagnosed polymyalgia rheumatica and temporal arteritis in the United Kingdom, 1990-2001. Ann Rheum Dis 2006;65:1093-8.
2. Lfawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35.
3. Patil P, Williams M, Maw WW, et al. Fast track pathway reduces sight loss in giant cell arteritis: results of a longitudinal observational cohort study. Clin Exp Rheumatol 2015;33.
4. Diamantopoulos AP, Haugeberg G, Lindland A, et al. The fast-track ultrasound clinic for early diagnosis of giant cell arteritis significantly reduces permanent visual impairment: towards a more effective strategy to improve clinical outcome in giant cell arteritis Rheumatology 2016;55:66-70.
5. Dfejaco C, Duftner C, Buttgereit F, et al. The spectrum of giant cell arteritis and polymyalgia rheumatica: revisiting the concept of the disease. Rheumatology 2017;56:506-15.
6. Pfrieto-González S, Arguis P, Cid MC. Imaging in systemic vasculitis. Curr Opin Rheumatol 2015;27:53-62.
7. Monti S, Floris A, Ponte C, et al. The use of ultrasound to assess giant cell arteritis: review of the current evidence and practical guide for the rheumatologist. Rheumatology 2017 [Epub ahead of print].
8. Dfireskeneli H. Clinical assessment in Takayasu's arteritis: major challenges and controversies. Clin Exp Rheumatol 2017;35:189-93.
9. vfan der Heijde D, Aletaha D, Carmona L, et al. 2014 Update of the EULAR standardised operating procedures for EULAR-endorsed recommendations. Ann Rheum Dis 2015;74:8-13.
10. Wfhiting PF, Rutjes AW, Westwood ME, et al. QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 2011;155:529-36.
11. Hfayden JA, Côté P, Bombardier C. Evaluation of the quality of prognosis studies in systematic reviews. Ann Intern Med 2006;144:427-37.
12. Duftner C, Dejaco C, Sepriano A, et al. Imaging in diagnosis, monitoring and outcome prediction of large vessel vasculitis: a systematic literature review and meta-analysis informing the EULAR recommendations. RMD open. submitted.
13. OCEBM Levels of Evidence Working Group. The Oxford 2011 levels of evidence, 2011. http://www. cebm. net/ index. aspx o= 5653
14. Sfalvarani C, Cimino L, Macchioni P, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum 2005;53:293-7.
15. Lfuqmani R, Lee E, Singh S, et al. The role of ultrasound compared to biopsy of temporal arteries in the diagnosis and treatment of giant cell arteritis (TABUL): a diagnostic accuracy and cost-effectiveness study. Health Technol Assess 2016;20:1-238.
16. Sfchmidt WA, Kraft HE, Vorpahl K, et al. Color duplex ultrasonography in the diagnosis of temporal arteritis. N Engl J Med 1997;337:1336-42.
17. Kfarahaliou M, Vaiopoulos G, Papaspyrou S, et al. Colour duplex sonography of temporal arteries before decision for biopsy: a prospective study in 55 patients with suspected giant cell arteritis. Arthritis Res Ther 2006;8:R116.
18. Hfauenstein C, Reinhard M, Geiger J, et al. Effects of early corticosteroid treatment on magnetic resonance imaging and ultrasonography findings in giant cell arteritis. Rheumatology 2012;51:1999-2003.
19. Gfunawardene AR, Chant H. Facial nerve injury during temporal artery biopsy. Ann R Coll Surg Engl 2014;96:257-60.
20. Gfermanò G, Muratore F, Cimino L, et al. Is colour duplex sonography-guided temporal artery biopsy useful in the diagnosis of giant cell arteritis A randomized study. Rheumatology 2015;54:400-4.
21. Sfchmidt WA, Seifert A, Gromnica-Ihle E, et al. Ultrasound of proximal upper extremity arteries to increase the diagnostic yield in large-vessel giant cell arteritis. Rheumatology 2008;47:96-101.
22. Mfuratore F, Kermani TA, Crowson CS, et al. Large-vessel giant cell arteritis: a cohort study. Rheumatology 2015;54:463-70.
23. Bfrack A, Martinez-Taboada V, Stanson A, et al. Disease pattern in cranial and largevessel giant cell arteritis. Arthritis Rheum 1999;42:311-7.
24. Gfriner PF, Mayewski RJ, Mushlin AI, et al. Selection and interpretation of diagnostic tests and procedures. Principles and applications. Ann Intern Med 1981;94:557-92.
25. Rfudwaleit M, van der Heijde D, Khan MA, et al. How to diagnose axial spondyloarthritis early. Ann Rheum Dis 2004;63:535-43.
26. Chrysidis S, Duftner C, Dejaco C, et al. Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group. RMD open;2017. submitted.
27. Afschwanden M, Daikeler T, Kesten F, et al. Temporal artery compression sign-a novel ultrasound finding for the diagnosis of giant cell arteritis. Ultraschall Med 2013;34:47-50.
28. Aschwanden M, Imfeld S, Staub D, et al. The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement. Clin Exp Rheumatol 2015;33.
29. Nfesher G, Shemesh D, Mates M, et al. The predictive value of the halo sign in color Doppler ultrasonography of the temporal arteries for diagnosing giant cell arteritis. J Rheumatol 2002;29:1224-6.
30. Pffadenhauer K, Weber H. Ultrasonography of the temporal, periorbital and carotid arteries in the diagnosis of giant cell arteritis and its neuroophthalmological complications. Ultraschall Med 2006;27:329-35.
31. Dfiamantopoulos AP, Haugeberg G, Hetland H, et al. Diagnostic value of color Doppler ultrasonography of temporal arteries and large vessels in giant cell arteritis: a consecutive case series. Arthritis Care Res 2014;66:113-9.
32. Bfley TA, Reinhard M, Hauenstein C, et al. Comparison of duplex sonography and high-resolution magnetic resonance imaging in the diagnosis of giant cell (temporal) arteritis. Arthritis Rheum 2008;58:2574-8.
33. Sfiemonsen S, Brekenfeld C, Holst B, et al. 3T MRI reveals extra-and intracranial involvement in giant cell arteritis. AJNR Am J Neuroradiol 2015;36:91-7.
34. Afschwanden M, Kesten F, Stern M, et al. Vascular involvement in patients with giant cell arteritis determined by duplex sonography of 2x11 arterial regions. Ann Rheum Dis 2010;69:1356-9.
35. Lfariviere D, Benali K, Coustet B, et al. Positron emission tomography and computed tomography angiography for the diagnosis of giant cell arteritis: A real-life prospective study. Medicine 2016;95:e4146.
36. Bflockmans D, Stroobants S, Maes A, et al. Positron emission tomography in giant cell arteritis and polymyalgia rheumatica: evidence for inflammation of the aortic arch. Am J Med 2000;108:246-9.
37. Pfuppo C, Massollo M, Paparo F, et al. Giant cell arteritis: a systematic review of the qualitative and semiquantitative methods to assess vasculitis with 18F-fluorodeoxyglucose positron emission tomography. Biomed Res Int 2014;2014:1-11.
38. Yfamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: diagnosis with breathhold contrast-enhanced three-dimensional MR angiography. J Magn Reson Imaging 2000;11:481-7.
39. Yfamada I, Nakagawa T, Himeno Y, et al. Takayasu arteritis: evaluation of the thoracic aorta with CT angiography. Radiology 1998;209:103-9.
40. Gfülcü A, Gezer NS, Akar S, et al. Long-term follow-up of endovascular repair in the management of arterial stenosis caused by takayasu's arteritis. Ann Vasc Surg 2017;42:93-100.
41. Bflockmans D, de Ceuninck L, Vanderschueren S, et al. Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients. Arthritis Rheum 2006;55:131-7.
42. Dfe Miguel E, Roxo A, Castillo C, et al. The utility and sensitivity of colour Doppler ultrasound in monitoring changes in giant cell arteritis. Clin Exp Rheumatol 2012;30:S34-8.
43. Hfabib HM, Essa AA, Hassan AA. Color duplex ultrasonography of temporal arteries: role in diagnosis and follow-up of suspected cases of temporal arteritis. Clin Rheumatol 2012;31:231-7.
44. Pférez López J, Solans Laqué R, Bosch Gil JA, et al. Colour-duplex ultrasonography of the temporal and ophthalmic arteries in the diagnosis and follow-up of giant cell arteritis. Clin Exp Rheumatol 2009;27:S77-82.
45. Pffadenhauer K, Weber H. Duplex sonography of the temporal and occipital artery in the diagnosis of temporal arteritis. A prospective study. J Rheumatol 2003;30:2177-81.
46. Salvarani C, Silingardi M, Ghirarduzzi A, et al. Is duplex ultrasonography useful for the diagnosis of giant-cell arteritis Ann Intern Med 2002;137:232-8.
47. Sfchmidt WA, Moll A, Seifert A, et al. Prognosis of large-vessel giant cell arteritis. Rheumatology 2008;47:1406-8.
48. Sfchmidt WA, Natusch A, Möller DE, et al. Involvement of peripheral arteries in giant cell arteritis: a color Doppler sonography study. Clin Exp Rheumatol 2002;20:309-18.
49. Gfarcía-Martínez A, Arguis P, Prieto-González S, et al. Prospective long term follow-up of a cohort of patients with giant cell arteritis screened for aortic structural damage (aneurysm or dilatation). Ann Rheum Dis 2014;73:1826-32.
50. Bflockmans D, Coudyzer W, Vanderschueren S, et al. Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology 2008;47:1179-84.
51. Rfobson JC, Kiran A, Maskell J, et al. The relative risk of aortic aneurysm in patients with giant cell arteritis compared with the general population of the UK. Ann Rheum Dis 2015;74:129-35.
52. Dfasgupta B, Borg FA, Hassan N, et al. BSR and BHPR guidelines for the management of giant cell arteritis. Rheumatology 2010;49:1594-7.
53. Mfackie SL, Hensor EM, Morgan AW, et al. Should I send my patient with previous giant cell arteritis for imaging of the thoracic aorta A systematic literature review and meta-analysis. Ann Rheum Dis 2014;73:143-8.
54. Dfe Miguel E, Castillo C, Rodríguez A, et al. Learning and reliability of colour Doppler ultrasound in giant cell arteritis. Clin Exp Rheumatol 2009;27:S53-8.
55. Mukhtyar C, Guillevin L, Cid MC, et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009;68:318-23.